New research emphasizes that replacing ultra-processed foods with healthier alternatives may help significantly reduce the ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.

Diabetes, a widespread condition affecting approximately 13% of American adults, is often accompanied by complications such ...

A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study ...

Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published ...

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

Number 5: The FDA has approved Pavblu (aflibercept-ayyh), the fifth biosimilar referencing Eylea (aflibercept).1 The new ...

Scientists have detected lipid biomarkers in children and teenagers with obesity that indicate an increased risk of developing type 2 diabetes, liver and heart disease as adults. A one-year lifestyle ...

18 in the journal Neurology ... For the study, researchers analyzed data on nearly 359,000 people with type 2 diabetes who started taking diabetes meds between 2014 and 2019 in South Korea.